New ASCO Guideline on HER2-negative metastatic Breast Cancer

被引：0
|
作者：
Lorenz, Judith
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2022年 / 82卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Advances in chemotherapy for HER2-negative metastatic breast cancer
    Mukai, Hirofumi
    Ito, Mayuko
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [2] Current approaches to the management of Her2-negative metastatic breast cancer
    Gogineni, Keerthi
    DeMichele, Angela
    BREAST CANCER RESEARCH, 2012, 14 (02)
  • [3] Bevacizumab in HER2-negative non-metastatic breast cancer
    Bennet, Neil
    LANCET ONCOLOGY, 2012, 13 (03): : E93 - E93
  • [4] Current approaches to the management of Her2-negative metastatic breast cancer
    Keerthi Gogineni
    Angela DeMichele
    Breast Cancer Research, 14
  • [5] Activating HER2 missense mutations in HER2-negative metastatic breast cancer
    Shah, Mirat
    Ensminger, Jennifer
    Wang, Chenguang
    Ali, Siraj
    Chung, Jon
    Lauring, Josh
    Park, Ben Ho
    Stearns, Vered
    CANCER RESEARCH, 2020, 80 (04)
  • [6] Maintenance Therapy in HER2-Negative Metastatic Breast Cancer: A New Approach for an Old Concept
    Eva Ciruelos
    José Manuel Pérez-García
    Joaquín Gavilá
    Analía Rodríguez
    Juan de la Haba-Rodriguez
    Clinical Drug Investigation, 2019, 39 : 595 - 606
  • [7] Maintenance Therapy in HER2-Negative Metastatic Breast Cancer: A New Approach for an Old Concept
    Ciruelos, Eva
    Manuel Perez-Garcia, Jose
    Gavila, Joaquin
    Rodriguez, Analia
    de la Haba-Rodriguez, Juan
    CLINICAL DRUG INVESTIGATION, 2019, 39 (07) : 595 - 606
  • [8] Use of Taxanes in Metastatic HER2-negative Breast Cancer - a Status Report
    Gluz, Oleg
    Kolberg-Liedtke, Cornelia
    Marme, Frederik
    Thill, Marc
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (04) : 399 - 409
  • [9] EVOLUTION OF CHEMOTHERAPY OPTIONS IN HER2-NEGATIVE METASTATIC BREAST CANCER (MBC)
    Verma, S.
    Zielinski, C.
    Martin, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 98 - 99
  • [10] Optimizing the management of HER2-negative metastatic breast cancer with capecitabine (Xeloda)
    Leonard, R
    Miles, D
    Reichardt, P
    Twelves, C
    SEMINARS IN ONCOLOGY, 2004, 31 (05) : 21 - 28
12345